Table 2

Operative parameters for the 217 adults in this study cohort.

ParameterValue
Levels fused, median (range)4 (1,16)
Personalized interbody devices per subject, mean (SD, range)1.7 (0.8, 1–5)
Patients with ALIF, n (%)99 (45.6)
Patients with LLIF, n (%)53 (24.4)
Patients with TLIF, n (%)80 (36.9)
Personalized ALIF, n (% of total)145 (39.7)
 L3/L4, n (% of ALIF)9 (6.2)
 L4/L5, n (% of ALIF)46 (31.7)
 L5/S1, n (% of ALIF)90 (62.1)
Personalized LLIF, n (% of total)99 (27.1)
 L1/L2, n (% of LLIF)15 (15.2)
 L2/L3, n (% of LLIF)38 (38.4)
 L3/L4, n (% of LLIF)29 (29.3)
 L4/L5, n (% of LLIF)17 (17.2)
Personalized TLIF, n (% of total)121 (33.1)
 L1/L2, n (% of TLIF)3 (2.5)
 L2/L3, n (% of TLIF)1 (0.8)
 L3/L4, n (% of TLIF)12 (9.9)
 L4/L5, n (% of TLIF)50 (41.3)
 L5/S1, n (% of TLIF)55 (45.5)
  • Abbreviations: ALIF, anterior lumbar interbody fusion; LLIF, lateral lumbar interbody fusion; TLIF, transforaminal lumbar interbody fusion.